Claudio Laudani,Felice Gragnano,Mattia Galli
Claudio Laudani
Clinical outcomes with the use of aspirin versus clopidogrel as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation [0.03%]
冠状动脉支架植入后的房颤患者口服抗凝剂联合阿司匹林或氯吡格雷治疗的临床疗效分析
Soo Hyun Kim,Soyoon Park,Hwajung Kim et al.
Soo Hyun Kim et al.
Aims: Patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI) are recommended to receive double antithrombotic therapy including an antiplatelet agent and direct anticoagulants (DOAC). ...
Joseph Edgar Blais,Angel Y S Wong
Joseph Edgar Blais
SGLT-2 inhibitors in cancer patients with diabetes: When cardioprotection is key [0.03%]
糖尿病癌症患者中的SGLT2抑制剂：心血管保护是关键
Mattia Brambilla,Bianca Larroux,Aldo Bonaventura
Mattia Brambilla
Association between sacubitril/valsartan and risk of dementia in patients with heart failure: a nationwide cohort study [0.03%]
沙库必曲/缬沙坦与心力衰竭患者痴呆风险的关系：一项全国性队列研究
Kyungyeon Jung,Ju Hwan Kim,Sungho Bea et al.
Kyungyeon Jung et al.
Aims: To evaluate risk of incident dementia associated with sacubitril/valsartan in patients with heart failure (HF) in South Korea. Methods and results: ...
Management of dyslipidaemia in patients with comorbidities-facing the challenge: type 1 diabetes mellitus [0.03%]
合并症患者的血脂管理：面临挑战：1型糖尿病 Mellitus
Susanne Kaser,Dobromir Dobrev,Bianca Rocca et al.
Susanne Kaser et al.
Type 1 diabetes is associated with excess cardiovascular risk. In contrast to type 2 diabetes, however, age at the onset of type 1 diabetes and sex are major predictors of cardiovascular risk, while the role of low-density lipoprotein chole...
Tolerability and efficacy of sodium-glucose co-transporter 2 inhibitors in patients with cardiac amyloidosis: a meta-analysis of observational studies [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂在心脏淀粉样变患者中的耐受性和有效性：观察性研究的meta分析
Renzo Laborante,Stefano Elia,Gianluigi Savarese et al.
Renzo Laborante et al.
Aims: The role of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with cardiac amyloidosis (CA) is controversial. However, they have shown encouraging results in several clinical settings, including heart f...
Efficacy of Pharmacological Therapies in Reducing Outflow Tract Obstruction in Patients with Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis [0.03%]
药物治疗梗阻性肥厚型心肌病流出道梗阻的有效性的系统评价和 meta 分析
Kamal Awad,Milagros Pereyra,Juan M Farina et al.
Kamal Awad et al.
Aims: Significant advancements have been made in the management of obstructive hypertrophic cardiomyopathy (oHCM), yet the extent of left ventricular outflow tract (LVOT) gradient reduction achieved with commonly used pha...
Sex-Related Variations in Platelet Reactivity in Presence or Absence of Antiplatelet Therapy [0.03%]
抗血小板治疗背景下血小板反应的性别差异分析研究
Mattia Galli,Sergio Terracina,Eleonora Schiera et al.
Mattia Galli et al.
Aims: Emerging evidence suggests sex-specific differences in platelet biology and clinical responses to antiplatelet agents. Light transmission aggregometry (LTA) represents the historical gold standard for the assessment...
Comparative effectiveness and safety of dual antiplatelet therapy with ticagrelor versus clopidogrel in older adults with acute coronary syndrome: a target trial emulation study [0.03%]
替格瑞洛与氯吡格雷在急性冠脉综合征老年患者中双重抗血小板治疗有效性和安全性的比较：靶向试验模拟研究
Carole A Marxer,Paul Hjemdahl,Juan J Carrero et al.
Carole A Marxer et al.
Aims: There is conflicting trial evidence on the comparative effects of dual antiplatelet therapy (DAPT) with ticagrelor vs. clopidogrel in older patients with acute coronary syndromes (ACS). We aimed to assess the risk o...